← Back to Patent Explorer
US4634689A Expired / Lapsed US ⏱️ 0.0 years remaining

Phosphinylalkanoyl imino acids

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1985-10-31
•
Granted: 1987-01-06
•
Expires: 2005-10-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Phosphinylalkanoyl imino acids useful in the treatment of hypertension are disclosed.

Inventors

  • 👤 Joseph T. Witkowski
  • 👤 Michael F. Czarniecki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 12:35
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/6536; C07F9/6544; C07F9/6547

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 401 words
A compound represented by the formula ##STR26## wherein X is ##STR27## D is ##STR28## or a bond; m, n, and r are independently 0-14; x is 1-4; p and q are independently 0 or 1, provided that the sum of p and q is 1 or 2; s is 2 or 3; t is 1-3; R is hydrogen, lower alkyl, halogen-substituted lower alkyl, cycloloweralkyl, --(CH 2 ) u -cycloloweralkyl, or --(CH 2 ) v --C 6 H 5 , wherein u is 1-4 and v is 0-4; R 1 is hydroxy, alkoxy having from 1 to 8 carbon atoms, phenylloweralkoxy, allyloxy, R 9 --Q w --(CH 2 ) y --O--, wherein Q is oxygen or sulfur, w is 0 or 1 and y is 2 to 4, ##STR29## wherein the alkyl has from 3 to 8 carbon atoms, ##STR30## wherein the phenyl may be substituted with group T defined below, 1-glyceryl, ##STR31## R 2 is R or heterocycloloweralkyl, wherein heterocyclo is a 5- or 6-membered aliphatic or aromatic ring of 3 to 5 carbon atoms and 1 to 3 heteroatoms selected from nitrogen, sulfur and oxygen; R 3 is hydrogen or lower alkyl; R 4 and R 5 are independently hydrogen, lower alkyl or cycloloweralkyl, or R 4 and R 5 together with the carbon atoms to which they are attached form a 5- or 6-membered ring; R 6 and R 7 are independently hydrogen, lower alkyl or cycloloweralkyl, or R 6 and R 7 together with the nitrogen and carbon atoms to which they are attached form a 4-, 6-, 7- or 8-membered ring; R 8 is R 1 , amino, hydroxylamino, mono- or disubstituted amino wherein the substituents are lower alkyl, phenyl or phenylloweralkyl, and wherein the phenyl may be substituted with group T defined below; R 9 is phenyl, substituted phenyl wherein the substituents are chosen from group T, 1-naphthyl or 2-naphthyl; T is halogen, hydroxy, trifluoromethyl, lower alkoxy, lower alkyl, 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, phenyl and substituted phenyl wherein the substituents are chosen from halogen, hydroxy, trifluoromethyl, lower alkoxy or lower alkyl; R 10 is hydrogen or alkyl having from 1 to 8 carbon atoms; R 11 is hydrogen, lower alkyl, unsubstituted or substituted phenyl and substituted or unsubstituted phenylloweralkyl wherein phenyl may be substituted by group T; R 12 is hydrogen or lower alkyl; R 13 is chloro or trifluoromethyl; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 401 words
A compound represented by the formula ##STR26## wherein X is ##STR27## D is ##STR28## or a bond; m, n, and r are independently 0-14; x is 1-4; p and q are independently 0 or 1, provided that the sum of p and q is 1 or 2; s is 2 or 3; t is 1-3; R is hydrogen, lower alkyl, halogen-substituted lower alkyl, cycloloweralkyl, --(CH 2 ) u -cycloloweralkyl, or --(CH 2 ) v --C 6 H 5 , wherein u is 1-4 and v is 0-4; R 1 is hydroxy, alkoxy having from 1 to 8 carbon atoms, phenylloweralkoxy, allyloxy, R 9 --Q w --(CH 2 ) y --O--, wherein Q is oxygen or sulfur, w is 0 or 1 and y is 2 to 4, ##STR29## wherein the alkyl has from 3 to 8 carbon atoms, ##STR30## wherein the phenyl may be substituted with group T defined below, 1-glyceryl, ##STR31## R 2 is R or heterocycloloweralkyl, wherein heterocyclo is a 5- or 6-membered aliphatic or aromatic ring of 3 to 5 carbon atoms and 1 to 3 heteroatoms selected from nitrogen, sulfur and oxygen; R 3 is hydrogen or lower alkyl; R 4 and R 5 are independently hydrogen, lower alkyl or cycloloweralkyl, or R 4 and R 5 together with the carbon atoms to which they are attached form a 5- or 6-membered ring; R 6 and R 7 are independently hydrogen, lower alkyl or cycloloweralkyl, or R 6 and R 7 together with the nitrogen and carbon atoms to which they are attached form a 4-, 6-, 7- or 8-membered ring; R 8 is R 1 , amino, hydroxylamino, mono- or disubstituted amino wherein the substituents are lower alkyl, phenyl or phenylloweralkyl, and wherein the phenyl may be substituted with group T defined below; R 9 is phenyl, substituted phenyl wherein the substituents are chosen from group T, 1-naphthyl or 2-naphthyl; T is halogen, hydroxy, trifluoromethyl, lower alkoxy, lower alkyl, 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, phenyl and substituted phenyl wherein the substituents are chosen from halogen, hydroxy, trifluoromethyl, lower alkoxy or lower alkyl; R 10 is hydrogen or alkyl having from 1 to 8 carbon atoms; R 11 is hydrogen, lower alkyl, unsubstituted or substituted phenyl and substituted or unsubstituted phenylloweralkyl wherein phenyl may be substituted by group T; R 12 is hydrogen or lower alkyl; R 13 is chloro or trifluoromethyl; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 12 words
A compound of claim 1 wherein Z is represented by formula IIIa.
Claim 4
Dependent Claim 9 words
A compound of claim 2 wherein A is ##STR32##
Claim 5
Dependent Claim 9 words
A compound of claim 3 wherein D is ##STR33##
Claim 6
Dependent Claim 10 words
A compound of claim 3 wherein D is a bond.
Claim 7
Dependent Claim 9 words
A compound of claim 2 wherein A is ##STR34##
Claim 8
Dependent Claim 12 words
A compound of claim 1 wherein Z is represented by formula IIIb.
Claim 9
Dependent Claim 9 words
A compound of claim 7 wherein B is ##STR35##
Claim 10
Dependent Claim 10 words
A compound of claim 7 wherein B is a bond.
Claim 11
Dependent Claim 9 words
A compound of claim 7 wherein B is ##STR36##
Claim 12
Dependent Claim 9 words
A compound of claim 10 wherein D is ##STR37##
Claim 13
Dependent Claim 10 words
A compound of claim 10 wherein D is a bond.
Claim 14
Dependent Claim 12 words
A compound of claim 1 wherein X is represented by formula IIa.
Claim 15
Dependent Claim 12 words
A compound of claim 1 wherein X is represented by formula IIb.
Claim 16
Dependent Claim 12 words
A compound of claim 1 wherein X is represented by formula IIc.
Claim 17
Dependent Claim 12 words
A compound of claim 1 wherein X is represented by formula IId.
Claim 18
Dependent Claim 12 words
A compound of claim 1 wherein X is represented by formula IIe.
Claim 19
Dependent Claim 10 words
A compound of claim 14 wherein each Y is --S--.
Claim 20
Dependent Claim 21 words
An antihypertensive pharmaceutical composition comprising an antihypertensive effective amount of a compound of claim 1 together with a pharmaceutically acceptable carrier.
Claim 21
Dependent Claim 26 words
A method of reducing blood pressure in hypertensive mammals which comprises administering to a hypertensive mammal a antihypertensive effective amount of a compound of claim 1.
Claim 22
Dependent Claim 22 words
A method for reducing blood pressure in an hypertensive mammals which comprises administering to a hypertensive mammal pharmaceutical composition of claim 19.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-01-05 1990-07-07 1991-01-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-01-05 1994-07-07 1995-01-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-01-05 1998-07-07 1999-01-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag